DR. JOHN B BUSE, MD
Osteopathic Medicine at Manning Dr, Chapel Hill, NC
License number
North Carolina 9400739
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
101 Manning Dr, Chapel Hill, NC 27599
Phone
(919) 966-4996
(919) 843-5515 (Fax)
(919) 843-5515 (Fax)
Personal information
See more information about JOHN B BUSE at radaris.comName
Address
Phone
102, Chapel Hill, NC 27514
3001 Pratt St #C, Durham, NC 27705
102 Silo Dr, Chapel Hill, NC 27514
Organization information
See more information about JOHN B BUSE at bizstanding.comUnc Clinic - John B Buse MD
101 Manning Dr #7001J, Chapel Hill, NC 27514
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Physicians & Surgeons
Phone:
(919) 966-7890 (Phone)
Professional information
Small Volume In Vitro Analyte Sensor With Diffusible Or Non-Leachable Redox Mediator
US Patent:
6591125, Jul 8, 2003
Filed:
Jun 27, 2000
Appl. No.:
09/604614
Inventors:
John Bernard Buse - Chapel Hill NC
Alan Charles Moses - Newton Centre MA
Alan Charles Moses - Newton Centre MA
Assignee:
TheraSense, Inc. - Alameda CA
International Classification:
A61B 505
US Classification:
600347, 600345, 600365
Abstract:
A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e. g. , by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e. g. , glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
John B Buse, Durham NC
Specialties:
Internist
Address:
5316 Highgate Dr, Durham, NC 27713
101 Manning Dr, Chapel Hill, NC 27514
101 Manning Dr, Chapel Hill, NC 27514
Education:
Duke University, School of Medicine - Doctor of Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Fellowship - Endocrinology
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Internal Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Fellowship - Endocrinology
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
John Bernard Buse, Chapel Hill NC
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
Ambulatory Care Svc
101 Manning Dr, Chapel Hill, NC 27514 Unc Highgate Specialty Center
5316 Highgate Dr, Durham, NC 27713
101 Manning Dr, Chapel Hill, NC 27514 Unc Highgate Specialty Center
5316 Highgate Dr, Durham, NC 27713
Education:
Duke University(1986)
Method Of Estimation Of Blood Glucose Excursions In Diabetic Patients Using 1,5-Anhydroglucitol (1,5-Ag) Assay
US Patent:
8178312, May 15, 2012
Filed:
Apr 21, 2006
Appl. No.:
11/912171
Inventors:
John B. Buse - Chapel Hill NC, US
Kathleen Dungan - Columbus OH, US
Steven D. Wittlin - Rochester NY, US
Eric A. Button - Kannapolis NC, US
Shuhei Kato - Tokyo, JP
Toshio Tanabe - Tokyo, JP
Kathleen Dungan - Columbus OH, US
Steven D. Wittlin - Rochester NY, US
Eric A. Button - Kannapolis NC, US
Shuhei Kato - Tokyo, JP
Toshio Tanabe - Tokyo, JP
Assignee:
Nippon Kayaku Kabushiki Kaisha - Tokyo
Toyota Tsusho America, Inc. - New York NY
Toyota Tsusho America, Inc. - New York NY
International Classification:
C12Q 1/54
US Classification:
435 14
Abstract:
The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.
Methods Of Determining Concentration Of Glucose
US Patent:
7740581, Jun 22, 2010
Filed:
Sep 29, 2005
Appl. No.:
11/238907
Inventors:
John Bernard Buse - Chapel Hill NC, US
Alan Charles Moses - Newtown Centre MA, US
Alan Charles Moses - Newtown Centre MA, US
Assignee:
Abbott Diabetes Care Inc. - Alameda CA
International Classification:
A61B 5/00, A61B 5/05
US Classification:
600365, 600347, 600573
Abstract:
A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e. g. , by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e. g. , glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
Methods Of Determining Analyte Concentration
US Patent:
8532731, Sep 10, 2013
Filed:
May 8, 2009
Appl. No.:
12/463183
Inventors:
John Bernard Buse - Chapel Hill NC, US
Alan Charles Moses - Newton Centre MA, US
Alan Charles Moses - Newton Centre MA, US
Assignee:
Abbott Diabetes Care Inc. - Alameda CA
International Classification:
A61B 5/05
US Classification:
600345, 600347, 20440304, 2044031, 205792
Abstract:
A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e. g. , by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e. g. , glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
Methods Of Determining Concentration Of Glucose
US Patent:
7058437, Jun 6, 2006
Filed:
Apr 17, 2003
Appl. No.:
10/418396
Inventors:
John Bernard Buse - Chapel Hill NC, US
Alan Charles Moses - Newton Centre MA, US
Alan Charles Moses - Newton Centre MA, US
Assignee:
TheraSense, Inc. - Alameda CA
International Classification:
A61B 5/05
US Classification:
600347, 600345, 600365
Abstract:
A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e. g. , by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e. g. , glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
Integrated Sample Acquisition And Analyte Measurement Device
US Patent:
2008002, Jan 31, 2008
Filed:
Jul 30, 2007
Appl. No.:
11/830779
Inventors:
John Buse - Chapel Hill NC, US
Alan Moses - Newton Centre MA, US
Alan Moses - Newton Centre MA, US
Assignee:
TheraSense, Inc. - Alameda CA
International Classification:
A61B 5/157
US Classification:
600347000, 600365000, 600583000, 600584000
Abstract:
A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.